Biotechnology
The Biotechnology industry has a total of 600 stocks, with a combined market cap of $1.14 trillion and total revenue of $105.3 billion.
Market Cap
1.14T
Revenue
105.3B
Profits
-41.5B
PE Ratio
n/a
Profit Margin
-39.41%
Dividend Yield
0.04%
600 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.12B | 1.92% | 674,863 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.17B | 1.10% | 399,408 | 14.25B |
| 3 | ARGX | argenx SE | 50.44B | 1.95% | 168,752 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 47.74B | 0.95% | 498,011 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.41B | -0.37% | 61,532 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.95B | 1.91% | 1,015,138 | 447.02M |
| 7 | BNTX | BioNTech SE | 29.49B | 1.35% | 509,657 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.35B | 0.14% | 1,230,228 | 2.35B |
| 9 | GMAB | Genmab A/S | 20.68B | -0.89% | 842,693 | 3.85B |
| 10 | INCY | Incyte Corporation | 20.11B | 0.43% | 776,922 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.87B | -17.03% | 8,005,036 | - |
| 12 | MRNA | Moderna, Inc. | 18.27B | -4.01% | 6,759,250 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.75B | 0.31% | 1,725,795 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15.04B | 0.22% | 1,309,177 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 14.31B | -0.98% | 261,012 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.00B | -0.03% | 644,746 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.89B | 1.33% | 859,157 | - |
| 18 | EXEL | Exelixis, Inc. | 11.73B | -1.60% | 1,007,139 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.32B | 3.72% | 160,690 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.94B | -0.03% | 365,802 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.91B | 1.05% | 646,328 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 10.53B | -0.83% | 828,816 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 10.23B | -0.21% | 246,366 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.76B | -2.15% | 467,194 | 6.23M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.40B | 0.27% | 94,277 | 561.26M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.23B | 0.19% | 555,697 | 829.45M |
| 27 | NUVL | Nuvalent, Inc. | 8.33B | 0.76% | 235,093 | - |
| 28 | PRAX | Praxis Precision Medicines, Inc. | 8.29B | -4.17% | 362,346 | 7.46M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.25B | 1.30% | 603,725 | 1.24B |
| 30 | KRYS | Krystal Biotech, Inc. | 8.09B | -0.87% | 49,037 | 373.16M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.81B | 0.76% | 514,035 | 87.21M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.31B | 3.60% | 768,231 | 649.06M |
| 33 | PCVX | Vaxcyte, Inc. | 7.01B | 1.50% | 279,752 | - |
| 34 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.96B | 1.31% | 238,947 | 174.33M |
| 35 | IBRX | ImmunityBio, Inc. | 6.28B | -1.09% | 26,475,930 | 82.56M |
| 36 | BLTE | Belite Bio, Inc | 6.23B | 0.99% | 310,251 | - |
| 37 | GPCR | Structure Therapeutics Inc. | 6.22B | -0.49% | 278,666 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.10B | 1.04% | 327,259 | 1.78B |
| 39 | COGT | Cogent Biosciences, Inc. | 5.78B | 3.60% | 1,714,970 | - |
| 40 | KYMR | Kymera Therapeutics, Inc. | 5.67B | 1.27% | 289,794 | 43.74M |
| 41 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.40B | -1.00% | 391,130 | 1.54M |
| 42 | IMVT | Immunovant, Inc. | 5.39B | 2.15% | 876,198 | - |
| 43 | CRSP | CRISPR Therapeutics AG | 5.29B | -0.05% | 675,444 | 38.34M |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.18B | -0.25% | 158,260 | 209.22M |
| 45 | CELC | Celcuity Inc. | 5.17B | 1.51% | 427,729 | - |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.07B | 4.14% | 490,460 | 471.79M |
| 47 | CORT | Corcept Therapeutics Incorporated | 4.75B | 2.71% | 823,943 | 741.17M |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.70B | -0.60% | 412,083 | - |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.56B | 0.93% | 249,945 | - |
| 50 | ACAD | ACADIA Pharmaceuticals Inc. | 4.53B | -0.15% | 236,532 | 1.05B |
| 51 | TGTX | TG Therapeutics, Inc. | 4.51B | -1.03% | 642,453 | 531.90M |
| 52 | FOLD | Amicus Therapeutics, Inc. | 4.42B | 0.04% | 5,686,386 | 598.70M |
| 53 | CGON | CG Oncology, Inc. | 4.27B | -1.73% | 315,612 | 2.17M |
| 54 | ADMA | ADMA Biologics, Inc. | 4.06B | 1.97% | 604,439 | 488.56M |
| 55 | ACLX | Arcellx, Inc. | 4.01B | 2.50% | 331,866 | 35.90M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.96B | 0.11% | 104,500 | 251.23M |
| 57 | CNTA | Centessa Pharmaceuticals plc | 3.79B | 2.69% | 723,879 | 15.00M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.75B | -0.66% | 188,096 | 35.24M |
| 59 | TERN | Terns Pharmaceuticals, Inc. | 3.75B | 0.38% | 742,349 | - |
| 60 | LQDA | Liquidia Corporation | 3.65B | 3.28% | 862,404 | 69.22M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.61B | -0.99% | 1,210,102 | - |
| 62 | LEGN | Legend Biotech Corporation | 3.53B | 0.63% | 1,205,075 | 909.05M |
| 63 | VERA | Vera Therapeutics, Inc. | 3.30B | -2.08% | 486,002 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.29B | 1.92% | 525,615 | 7.50M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.27B | 3.46% | 795,790 | - |
| 66 | ARQT | Arcutis Biotherapeutics, Inc. | 3.25B | 1.37% | 578,776 | 317.93M |
| 67 | ALMS | Alumis Inc. | 3.19B | 4.40% | 1,223,570 | 22.12M |
| 68 | VRDN | Viridian Therapeutics, Inc. | 3.16B | 0.61% | 614,015 | 70.79M |
| 69 | BEAM | Beam Therapeutics Inc. | 3.13B | 0.41% | 603,739 | 55.70M |
| 70 | IDYA | IDEAYA Biosciences, Inc. | 3.05B | -0.14% | 486,891 | 214.83M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.97B | -1.78% | 276,877 | - |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.96B | 2.25% | 798,632 | 578.20M |
| 73 | IRON | Disc Medicine, Inc. | 2.95B | 2.38% | 197,588 | - |
| 74 | ERAS | Erasca, Inc. | 2.95B | -4.42% | 5,251,008 | - |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.94B | -0.94% | 999,443 | - |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.90B | 0.04% | 277,435 | 366.10M |
| 77 | ADPT | Adaptive Biotechnologies Corporation | 2.90B | 2.43% | 515,617 | 252.75M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.79B | 1.99% | 331,105 | 240.00M |
| 79 | IMNM | Immunome, Inc. | 2.77B | -2.90% | 1,478,507 | 9.68M |
| 80 | APLS | Apellis Pharmaceuticals, Inc. | 2.77B | 0.64% | 376,001 | 1.02B |
| 81 | TVTX | Travere Therapeutics, Inc. | 2.67B | 1.32% | 469,516 | 435.83M |
| 82 | MLYS | Mineralys Therapeutics, Inc. | 2.62B | 1.04% | 353,996 | - |
| 83 | TLX | Telix Pharmaceuticals Limited | 2.55B | 1.31% | 108,332 | 664.23M |
| 84 | SYRE | Spyre Therapeutics, Inc. | 2.53B | 1.79% | 157,141 | - |
| 85 | WVE | Wave Life Sciences Ltd. | 2.45B | -0.52% | 731,701 | 109.23M |
| 86 | RXRX | Recursion Pharmaceuticals, Inc. | 2.41B | -2.11% | 10,473,234 | 43.69M |
| 87 | SRPT | Sarepta Therapeutics, Inc. | 2.39B | 8.05% | 5,542,786 | 2.41B |
| 88 | MESO | Mesoblast Limited | 2.38B | 1.52% | 42,692 | 17.20M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.34B | 0.29% | 899,784 | 630.60M |
| 90 | AAPG | Ascentage Pharma Group International | 2.32B | -3.51% | 4,578 | 54.52M |
| 91 | SLNO | Soleno Therapeutics, Inc. | 2.29B | 0.52% | 622,460 | 98.68M |
| 92 | GLPG | Galapagos NV | 2.27B | 0.41% | 32,253 | 336.64M |
| 93 | OCUL | Ocular Therapeutix, Inc. | 2.26B | 3.12% | 1,579,725 | 55.78M |
| 94 | DNTH | Dianthus Therapeutics, Inc. | 2.17B | -3.11% | 256,540 | 3.08M |
| 95 | MAZE | Maze Therapeutics, Inc. | 2.16B | 1.51% | 211,793 | 2.50M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 2.15B | 1.41% | 312,053 | 825.94M |
| 97 | OLMA | Olema Pharmaceuticals, Inc. | 2.00B | 0.95% | 305,309 | - |
| 98 | ZLAB | Zai Lab Limited | 1.97B | -3.33% | 420,711 | 441.63M |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | 0.10% | 822,578 | 265.81M |
| 100 | NRIX | Nurix Therapeutics, Inc. | 1.92B | 1.89% | 290,224 | 83.69M |
| 101 | ARDX | Ardelyx, Inc. | 1.91B | 1.03% | 1,276,123 | 398.23M |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 1.90B | 7.80% | 1,410,360 | 111.30M |
| 103 | NUVB | Nuvation Bio Inc. | 1.89B | -1.43% | 2,040,747 | 26.75M |
| 104 | SION | Sionna Therapeutics, Inc. | 1.89B | -0.32% | 54,185 | - |
| 105 | VCEL | Vericel Corporation | 1.87B | -2.32% | 124,822 | 258.72M |
| 106 | CRVS | Corvus Pharmaceuticals, Inc. | 1.80B | -14.34% | 5,881,653 | - |
| 107 | PHVS | Pharvaris N.V. | 1.80B | -1.20% | 36,315 | - |
| 108 | GLUE | Monte Rosa Therapeutics, Inc. | 1.79B | -1.09% | 601,621 | 181.54M |
| 109 | IMCR | Immunocore Holdings plc | 1.79B | 0.83% | 189,105 | 379.59M |
| 110 | CLDX | Celldex Therapeutics, Inc. | 1.76B | 2.43% | 617,588 | 2.60M |
| 111 | BHVN | Biohaven Ltd. | 1.74B | -2.89% | 891,585 | - |
| 112 | MNKD | MannKind Corporation | 1.71B | 2.29% | 2,375,251 | 313.79M |
| 113 | ZYME | Zymeworks Inc. | 1.71B | -1.42% | 279,431 | 134.48M |
| 114 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 1.37% | 548,163 | 44.79M |
| 115 | DFTX | Definium Therapeutics, Inc. | 1.69B | -1.67% | 767,965 | - |
| 116 | NTLA | Intellia Therapeutics, Inc. | 1.68B | -0.68% | 2,987,365 | 57.53M |
| 117 | STOK | Stoke Therapeutics, Inc. | 1.67B | -0.71% | 155,870 | 205.63M |
| 118 | RAPT | RAPT Therapeutics, Inc. | 1.67B | 0.03% | 1,260,394 | - |
| 119 | ORKA | Oruka Therapeutics, Inc. | 1.66B | -0.52% | 130,735 | - |
| 120 | UPB | Upstream Bio, Inc. | 1.65B | 1.80% | 324,598 | 2.80M |
| 121 | PGEN | Precigen, Inc. | 1.65B | -2.31% | 2,333,967 | 6.31M |
| 122 | MBX | MBX Biosciences, Inc. | 1.64B | -3.38% | 441,720 | - |
| 123 | TYRA | Tyra Biosciences, Inc. | 1.62B | -0.23% | 242,711 | - |
| 124 | KOD | Kodiak Sciences Inc. | 1.60B | -0.46% | 265,836 | - |
| 125 | QURE | uniQure N.V. | 1.58B | 0.88% | 1,370,623 | 15.75M |
| 126 | NVAX | Novavax, Inc. | 1.57B | 5.13% | 5,314,802 | 1.06B |
| 127 | TNGX | Tango Therapeutics, Inc. | 1.56B | -0.94% | 603,288 | 66.50M |
| 128 | FTRE | Fortrea Holdings Inc. | 1.56B | 0.42% | 384,283 | 2.76B |
| 129 | OCS | Oculis Holding AG | 1.54B | -2.10% | 118,205 | 992.00K |
| 130 | ELVN | Enliven Therapeutics, Inc. | 1.54B | 0.39% | 299,590 | - |
| 131 | DBVT | DBV Technologies S.A. | 1.48B | -4.85% | 264,308 | 5.50M |
| 132 | INVA | Innoviva, Inc. | 1.46B | -0.26% | 239,785 | 388.52M |
| 133 | ATAI | AtaiBeckley Inc. | 1.43B | -5.30% | 2,599,664 | 3.02M |
| 134 | SVRA | Savara Inc. | 1.39B | -4.32% | 594,111 | - |
| 135 | PHAR | Pharming Group N.V. | 1.35B | 3.60% | 20,378 | 362.27M |
| 136 | IVA | Inventiva S.A. | 1.34B | -0.98% | 287,306 | 19.93M |
| 137 | ANAB | AnaptysBio, Inc. | 1.32B | 0.14% | 179,936 | 169.47M |
| 138 | IMTX | Immatics N.V. | 1.31B | -1.51% | 101,716 | 99.45M |
| 139 | RLAY | Relay Therapeutics, Inc. | 1.30B | 0.67% | 1,526,612 | 8.36M |
| 140 | TRVI | Trevi Therapeutics, Inc. | 1.30B | 1.10% | 696,936 | - |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | 1.07% | 1,036,976 | 6.31M |
| 142 | SANA | Sana Biotechnology, Inc. | 1.28B | -0.41% | 1,246,690 | - |
| 143 | RAPP | Rapport Therapeutics, Inc. | 1.27B | -0.98% | 336,804 | - |
| 144 | EYPT | EyePoint, Inc. | 1.27B | 0.79% | 337,092 | 42.34M |
| 145 | DAWN | Day One Biopharmaceuticals, Inc. | 1.25B | 1.63% | 759,671 | 133.67M |
| 146 | ABCL | AbCellera Biologics Inc. | 1.24B | -2.36% | 3,450,974 | 35.33M |
| 147 | XERS | Xeris Biopharma Holdings, Inc. | 1.24B | 0.13% | 570,522 | 266.14M |
| 148 | ORIC | ORIC Pharmaceuticals, Inc. | 1.22B | 4.59% | 2,263,530 | - |
| 149 | CAPR | Capricor Therapeutics, Inc. | 1.21B | 1.16% | 489,311 | 11.13M |
| 150 | SEPN | Septerna, Inc. | 1.17B | 1.65% | 84,014 | 22.05M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.15B | 1.70% | 606,440 | - |
| 152 | IOVA | Iovance Biotherapeutics, Inc. | 1.14B | 9.09% | 11,896,325 | 250.43M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.11B | -2.17% | 131,289 | 5.56M |
| 154 | PHAT | Phathom Pharmaceuticals, Inc. | 1.10B | 3.63% | 564,486 | 147.19M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.09B | 0.53% | 81,392 | 1.40M |
| 156 | CMPX | Compass Therapeutics, Inc. | 1.07B | 2.29% | 976,593 | 850.00K |
| 157 | NBTX | Nanobiotix S.A. | 1.04B | 2.67% | 2,796 | 11.93M |
| 158 | SPRY | ARS Pharmaceuticals, Inc. | 1.04B | 3.13% | 663,397 | 142.77M |
| 159 | VIR | Vir Biotechnology, Inc. | 1.04B | -1.52% | 754,141 | 16.86M |
| 160 | GHRS | GH Research PLC | 1.03B | -0.72% | 68,526 | - |
| 161 | ZBIO | Zenas BioPharma, Inc. | 1.03B | -4.68% | 246,007 | 15.00M |
| 162 | PVLA | Palvella Therapeutics, Inc. | 1.03B | 1.65% | 94,583 | - |
| 163 | VTYX | Ventyx Biosciences, Inc. | 1.00B | -0.43% | 975,732 | - |
| 164 | TBPH | Theravance Biopharma, Inc. | 994.70M | -3.01% | 143,417 | 80.33M |
| 165 | ANNX | Annexon, Inc. | 988.24M | -2.21% | 1,035,302 | - |
| 166 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 973.46M | -3.57% | 78,267 | - |
| 167 | URGN | UroGen Pharma Ltd. | 970.35M | 3.65% | 275,338 | 96.52M |
| 168 | AVBP | ArriVent BioPharma, Inc. | 965.36M | 0.73% | 166,169 | - |
| 169 | MRVI | Maravai LifeSciences Holdings, Inc. | 949.95M | 0.13% | 439,302 | 192.44M |
| 170 | XNCR | Xencor, Inc. | 926.19M | 1.49% | 129,542 | 150.13M |
| 171 | CTMX | CytomX Therapeutics, Inc. | 911.56M | -2.89% | 1,644,939 | 113.63M |
| 172 | BCAX | Bicara Therapeutics Inc. | 908.28M | -0.96% | 354,038 | - |
| 173 | GERN | Geron Corporation | 884.12M | 0.36% | 7,372,700 | 183.40M |
| 174 | JANX | Janux Therapeutics, Inc. | 875.75M | -1.69% | 1,022,441 | 10.00M |
| 175 | YDES | YD Bio Limited | 852.63M | -1.90% | 5,569 | 510.36K |
| 176 | DRUG | Bright Minds Biosciences Inc. | 851.32M | -1.47% | 27,237 | - |
| 177 | ARVN | Arvinas, Inc. | 847.76M | 2.40% | 354,656 | 312.30M |
| 178 | VALN | Valneva SE | 837.21M | -5.42% | 7,300 | 211.09M |
| 179 | OMER | Omeros Corporation | 821.03M | -2.93% | 757,900 | - |
| 180 | ENGN | enGene Holdings Inc. | 796.45M | -2.30% | 281,575 | - |
| 181 | ABUS | Arbutus Biopharma Corporation | 785.64M | 0.62% | 366,962 | 14.61M |
| 182 | MDXG | MiMedx Group, Inc. | 780.50M | 0.19% | 534,427 | 393.44M |
| 183 | KALV | KalVista Pharmaceuticals, Inc. | 778.16M | -3.90% | 342,242 | 1.43M |
| 184 | MPLT | MapLight Therapeutics, Inc. | 757.62M | -3.45% | 112,670 | - |
| 185 | NKTR | Nektar Therapeutics | 756.10M | 0.16% | 240,892 | 62.60M |
| 186 | PRME | Prime Medicine, Inc. | 748.87M | -4.51% | 1,279,952 | 5.98M |
| 187 | KURA | Kura Oncology, Inc. | 744.00M | -0.93% | 555,226 | 104.03M |
| 188 | ATXS | Astria Therapeutics, Inc. | 718.13M | 0.64% | 3,199,309 | 706.00K |
| 189 | FULC | Fulcrum Therapeutics, Inc. | 717.76M | 1.21% | 261,478 | 80.00M |
| 190 | CGEM | Cullinan Therapeutics, Inc. | 716.00M | -3.04% | 274,299 | - |
| 191 | GYRE | Gyre Therapeutics, Inc. | 714.40M | 0.13% | 14,801 | 107.27M |
| 192 | RGNX | REGENXBIO Inc. | 709.74M | 1.67% | 508,088 | 161.32M |
| 193 | JBIO | Jade Biosciences, Inc. | 705.24M | -5.98% | 205,593 | - |
| 194 | SLS | SELLAS Life Sciences Group, Inc. | 704.97M | -2.82% | 3,267,814 | - |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 666.15M | -0.70% | 127,327 | 282.08M |
| 196 | MGTX | MeiraGTx Holdings plc | 645.94M | -0.93% | 152,151 | 27.42M |
| 197 | PROK | ProKidney Corp. | 640.78M | -1.84% | 378,385 | 744.00K |
| 198 | LENZ | LENZ Therapeutics, Inc. | 637.69M | -0.29% | 276,734 | 17.50M |
| 199 | DRTS | Alpha Tau Medical Ltd. | 636.07M | 6.72% | 290,724 | - |
| 200 | EVMN | Evommune, Inc. | 616.93M | 3.71% | 223,055 | 13.00M |
| 201 | GOSS | Gossamer Bio, Inc. | 612.20M | -2.04% | 1,488,955 | 44.05M |
| 202 | ALT | Altimmune, Inc. | 605.81M | 0.91% | 3,544,602 | 20.00K |
| 203 | CRMD | CorMedix Inc. | 604.31M | 5.50% | 1,620,822 | 214.30M |
| 204 | DSGN | Design Therapeutics, Inc. | 598.97M | 3.29% | 1,100,072 | - |
| 205 | VOR | Vor Biopharma Inc. | 597.84M | -6.93% | 573,268 | - |
| 206 | REPL | Replimune Group, Inc. | 590.68M | -2.33% | 339,117 | - |
| 207 | IVVD | Invivyd, Inc. | 589.35M | -0.95% | 2,061,479 | 50.04M |
| 208 | FBRX | Forte Biosciences, Inc. | 583.98M | 2.66% | 208,273 | - |
| 209 | TENX | Tenax Therapeutics, Inc. | 581.37M | -2.52% | 153,766 | - |
| 210 | LXRX | Lexicon Pharmaceuticals, Inc. | 577.80M | -6.47% | 1,849,915 | 70.86M |
| 211 | KROS | Keros Therapeutics, Inc. | 573.07M | -2.03% | 74,248 | 246.72M |
| 212 | DNA | Ginkgo Bioworks Holdings, Inc. | 572.91M | 0.60% | 308,695 | 180.61M |
| 213 | LBRX | LB Pharmaceuticals Inc | 565.81M | -6.46% | 104,092 | - |
| 214 | LXEO | Lexeo Therapeutics, Inc. | 547.40M | - | 202,156 | - |
| 215 | PRTA | Prothena Corporation plc | 544.22M | 1.10% | 169,366 | 11.79M |
| 216 | OCGN | Ocugen, Inc. | 531.18M | -2.41% | 2,669,036 | 5.37M |
| 217 | LYEL | Lyell Immunopharma, Inc. | 529.40M | -1.35% | 39,604 | 41.00K |
| 218 | ANRO | Alto Neuroscience, Inc. | 519.58M | 0.69% | 111,794 | - |
| 219 | KYTX | Kyverna Therapeutics, Inc. | 513.02M | -7.99% | 726,677 | - |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 508.93M | 0.78% | 514,136 | 84.39M |
| 221 | SLDB | Solid Biosciences Inc. | 500.96M | -2.58% | 341,102 | - |
| 222 | NAGE | Niagen Bioscience, Inc. | 494.15M | 2.66% | 363,602 | 124.71M |
| 223 | BCYC | Bicycle Therapeutics plc | 490.43M | 1.73% | 102,124 | 28.34M |
| 224 | VSTM | Verastem, Inc. | 483.54M | -1.80% | 751,969 | 13.38M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 477.07M | 0.54% | 75,793 | - |
| 226 | MNPR | Monopar Therapeutics Inc. | 476.60M | -4.94% | 317,485 | - |
| 227 | IMMP | Immutep Limited | 465.73M | 0.32% | 242,453 | 3.31M |
| 228 | FDMT | 4D Molecular Therapeutics, Inc. | 462.79M | 1.76% | 276,554 | 120.00K |
| 229 | NBP | NovaBridge Biosciences | 461.16M | 2.83% | 382,931 | - |
| 230 | VNDA | Vanda Pharmaceuticals Inc. | 457.41M | -3.37% | 361,585 | 212.07M |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 455.47M | -3.00% | 44,514 | - |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 455.15M | -0.18% | 111,653 | - |
| 233 | AVXL | Anavex Life Sciences Corp. | 451.21M | -3.99% | 488,390 | - |
| 234 | PRTC | PureTech Health plc | 441.58M | 0.86% | 1,195 | 6.39M |
| 235 | ADCT | ADC Therapeutics SA | 441.00M | -1.39% | 356,213 | 75.21M |
| 236 | ASMB | Assembly Biosciences, Inc. | 438.45M | -1.04% | 64,437 | 37.19M |
| 237 | ABSI | Absci Corporation | 436.83M | -0.17% | 1,802,002 | 2.82M |
| 238 | ACRS | Aclaris Therapeutics, Inc. | 420.38M | -13.78% | 1,500,413 | 15.74M |
| 239 | ZURA | Zura Bio Limited | 417.45M | 0.94% | 313,238 | - |
| 240 | GLSI | Greenwich LifeSciences, Inc. | 415.64M | 17.79% | 593,644 | - |
| 241 | VTVT | vTv Therapeutics Inc. | 414.52M | -2.07% | 6,380 | 17.00K |
| 242 | BNTC | Benitec Biopharma Inc. | 414.14M | -2.00% | 57,446 | - |
| 243 | NBY | NovaBay Pharmaceuticals, Inc. | 403.12M | -32.17% | 1,363,002 | 10.30M |
| 244 | TRDA | Entrada Therapeutics, Inc. | 401.65M | -2.01% | 88,624 | 61.52M |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 392.85M | -2.42% | 891,732 | - |
| 246 | LCTX | Lineage Cell Therapeutics, Inc. | 392.04M | 0.48% | 494,166 | 10.82M |
| 247 | AUTL | Autolus Therapeutics plc | 372.60M | -4.11% | 1,086,425 | 51.13M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 371.75M | -1.08% | 86,436 | 65.32M |
| 249 | HELP | Cybin Inc. | 365.79M | -2.79% | 230,704 | - |
| 250 | TECX | Tectonic Therapeutic, Inc. | 364.59M | -3.37% | 100,489 | - |
| 251 | PEPG | PepGen Inc. | 362.30M | -3.30% | 289,746 | - |
| 252 | AURA | Aura Biosciences, Inc. | 353.08M | -2.11% | 78,276 | - |
| 253 | TARA | Protara Therapeutics, Inc. | 351.00M | 5.82% | 898,083 | - |
| 254 | NMRA | Neumora Therapeutics, Inc. | 349.22M | -0.24% | 314,299 | - |
| 255 | ACIU | AC Immune SA | 346.30M | -5.41% | 120,078 | 5.48M |
| 256 | ALLO | Allogene Therapeutics, Inc. | 340.47M | -11.92% | 4,995,969 | 22.00K |
| 257 | FHTX | Foghorn Therapeutics Inc. | 339.77M | -1.36% | 61,945 | 24.52M |
| 258 | GUTS | Fractyl Health, Inc. | 338.95M | 5.74% | 5,222,814 | 3.00K |
| 259 | IMRX | Immuneering Corporation | 337.70M | -2.43% | 653,217 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 331.04M | -2.74% | 419,287 | - |
| 261 | AARD | Aardvark Therapeutics, Inc. | 327.03M | 0.07% | 49,984 | - |
| 262 | XFOR | X4 Pharmaceuticals, Inc. | 323.52M | - | 131,469 | 33.98M |
| 263 | XOMA | XOMA Royalty Corporation | 323.45M | -2.17% | 876,375 | 47.11M |
| 264 | PBYI | Puma Biotechnology, Inc. | 319.73M | -1.17% | 249,339 | 212.00M |
| 265 | RZLT | Rezolute, Inc. | 318.06M | -2.56% | 2,222,570 | - |
| 266 | CLLS | Cellectis S.A. | 317.62M | -7.24% | 55,737 | 82.55M |
| 267 | ALDX | Aldeyra Therapeutics, Inc. | 313.45M | 0.39% | 371,197 | - |
| 268 | AVIR | Atea Pharmaceuticals, Inc. | 305.87M | -4.98% | 383,904 | - |
| 269 | LRMR | Larimar Therapeutics, Inc. | 301.28M | -4.61% | 1,103,117 | - |
| 270 | RLMD | Relmada Therapeutics, Inc. | 298.47M | 4.36% | 363,954 | - |
| 271 | NGNE | Neurogene Inc. | 297.56M | 4.92% | 100,104 | 925.00K |
| 272 | AVTX | Avalo Therapeutics, Inc. | 293.80M | 0.76% | 161,147 | 192.00K |
| 273 | CABA | Cabaletta Bio, Inc. | 288.80M | -5.66% | 4,238,425 | - |
| 274 | IMMX | Immix Biopharma, Inc. | 285.08M | 0.56% | 462,456 | - |
| 275 | ABEO | Abeona Therapeutics Inc. | 284.23M | 1.65% | 639,822 | 400.00K |
| 276 | ENLV | Enlivex Therapeutics Ltd. | 282.48M | 10.19% | 510,343 | - |
| 277 | OABI | OmniAb, Inc. | 280.71M | -0.51% | 161,317 | 21.09M |
| 278 | ACHV | Achieve Life Sciences, Inc. | 278.95M | -6.43% | 462,188 | - |
| 279 | PALI | Palisade Bio, Inc. | 277.89M | -2.36% | 2,036,068 | - |
| 280 | CHRS | Coherus Oncology, Inc. | 271.36M | 8.98% | 6,349,567 | 277.73M |
| 281 | HRTX | Heron Therapeutics, Inc. | 263.13M | 1.06% | 309,056 | 155.10M |
| 282 | SLN | Silence Therapeutics plc | 263.09M | -1.76% | 176,492 | 25.83M |
| 283 | FENC | Fennec Pharmaceuticals Inc. | 262.64M | 0.39% | 34,177 | 38.79M |
| 284 | NAUT | Nautilus Biotechnology, Inc. | 257.66M | -1.45% | 99,914 | - |
| 285 | STTK | Shattuck Labs, Inc. | 255.02M | -2.89% | 290,413 | 1.00M |
| 286 | CBIO | Crescent Biopharma, Inc. | 234.40M | -6.33% | 105,969 | - |
| 287 | MDWD | MediWound Ltd. | 232.97M | 2.66% | 56,309 | 20.93M |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 229.11M | -3.74% | 256,249 | 1.00 |
| 289 | CLYM | Climb Bio, Inc. | 227.50M | -5.08% | 506,594 | - |
| 290 | VYGR | Voyager Therapeutics, Inc. | 225.46M | 1.37% | 243,764 | 31.32M |
| 291 | IPSC | Century Therapeutics, Inc. | 225.27M | 6.61% | 1,082,394 | 113.34M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 224.73M | -1.49% | 75,716 | 2.82M |
| 293 | MENS | Jyong Biotech Ltd. | 223.01M | -4.29% | 183,507 | - |
| 294 | OVID | Ovid Therapeutics Inc. | 221.96M | 0.89% | 1,259,609 | 6.61M |
| 295 | ARMP | Armata Pharmaceuticals, Inc. | 221.72M | 1.50% | 25,092 | 5.05M |
| 296 | TNXP | Tonix Pharmaceuticals Holding Corp. | 218.96M | -3.55% | 179,086 | 10.30M |
| 297 | NVCT | Nuvectis Pharma, Inc. | 217.39M | -1.20% | 11,796 | - |
| 298 | ALEC | Alector, Inc. | 215.03M | 1.55% | 408,301 | 69.05M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 209.70M | -1.99% | 172,465 | 97.60M |
| 300 | TLSA | Tiziana Life Sciences Ltd | 207.87M | 1.84% | 369,862 | - |
| 301 | GALT | Galectin Therapeutics Inc. | 207.60M | -2.72% | 135,940 | - |
| 302 | EDIT | Editas Medicine, Inc. | 205.00M | -2.78% | 919,439 | 46.38M |
| 303 | CCCC | C4 Therapeutics, Inc. | 203.52M | -2.33% | 422,789 | 30.11M |
| 304 | MIST | Milestone Pharmaceuticals Inc. | 199.10M | -1.01% | 2,204,202 | - |
| 305 | SABS | SAB Biotherapeutics, Inc. | 199.00M | 3.47% | 403,960 | 114.70K |
| 306 | SGMT | Sagimet Biosciences Inc. | 198.71M | -0.49% | 378,372 | - |
| 307 | CRDF | Cardiff Oncology, Inc. | 198.38M | 1.55% | 312,696 | 501.00K |
| 308 | HUMA | Humacyte, Inc. | 197.82M | -2.38% | 2,561,493 | 1.57M |
| 309 | RNAC | Cartesian Therapeutics, Inc. | 197.37M | -0.65% | 52,662 | 1.09M |
| 310 | IRD | Opus Genetics, Inc. | 195.17M | 10.55% | 765,666 | 14.63M |
| 311 | CGEN | Compugen Ltd. | 191.28M | -2.15% | 86,468 | 6.90M |
| 312 | CAMP | Camp4 Therapeutics Corporation | 188.33M | -9.48% | 80,241 | 3.80M |
| 313 | PRQR | ProQR Therapeutics N.V. | 186.46M | 1.14% | 222,199 | 18.86M |
| 314 | CNTX | Context Therapeutics Inc. | 185.60M | 11.60% | 3,272,573 | - |
| 315 | ZNTL | Zentalis Pharmaceuticals, Inc. | 184.49M | -3.09% | 600,163 | 26.87M |
| 316 | KLRS | Kalaris Therapeutics, Inc. | 184.03M | 0.41% | 19,223 | - |
| 317 | NKTX | Nkarta, Inc. | 177.57M | 0.40% | 456,654 | - |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 175.91M | 0.93% | 26,605 | 59.99K |
| 319 | SLGL | Sol-Gel Technologies Ltd. | 175.84M | 8.01% | 18,856 | 18.97M |
| 320 | NERV | Minerva Neurosciences, Inc. | 174.40M | 1.51% | 30,629 | - |
| 321 | ELDN | Eledon Pharmaceuticals, Inc. | 173.78M | 2.34% | 295,743 | - |
| 322 | PRLD | Prelude Therapeutics Incorporated | 170.97M | 2.72% | 124,224 | 10.50M |
| 323 | IPHA | Innate Pharma S.A. | 169.00M | -1.12% | - | 14.84M |
| 324 | QNCX | Quince Therapeutics, Inc. | 168.16M | -1.95% | 409,681 | - |
| 325 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 168.05M | 3.89% | 67,430 | - |
| 326 | SRZN | Surrozen, Inc. | 167.66M | -0.18% | 13,961 | 3.60M |
| 327 | RANI | Rani Therapeutics Holdings, Inc. | 167.09M | -1.08% | 529,410 | 1.20M |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 165.67M | -0.96% | 594,867 | 61.84M |
| 329 | VXRT | Vaxart, Inc. | 160.55M | -0.12% | 671,102 | 148.20M |
| 330 | TNYA | Tenaya Therapeutics, Inc. | 151.90M | -3.93% | 2,515,233 | - |
| 331 | MOLN | Molecular Partners AG | 149.91M | -0.37% | 965 | 856.30K |
| 332 | UNCY | Unicycive Therapeutics, Inc. | 147.22M | -1.01% | 280,148 | - |
| 333 | CNTB | Connect Biopharma Holdings Limited | 146.75M | 3.35% | 125,021 | 762.00K |
| 334 | BDTX | Black Diamond Therapeutics, Inc. | 145.57M | -2.11% | 493,806 | 70.00M |
| 335 | ELTX | Elicio Therapeutics, Inc. | 145.22M | 2.59% | 98,915 | - |
| 336 | FATE | Fate Therapeutics, Inc. | 143.04M | 2.48% | 782,626 | 7.14M |
| 337 | CDXS | Codexis, Inc. | 141.81M | -6.55% | 943,547 | 52.93M |
| 338 | CRBU | Caribou Biosciences, Inc. | 141.60M | -0.98% | 472,470 | 9.30M |
| 339 | TTRX | Turn Therapeutics Inc. | 140.45M | -1.85% | 6,243 | - |
| 340 | MCRB | Seres Therapeutics, Inc. | 140.18M | 2.96% | 47,521 | 351.00K |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 137.52M | 1.92% | 320,679 | 2.00M |
| 342 | SPRO | Spero Therapeutics, Inc. | 137.47M | - | 93,977 | 40.55M |
| 343 | ABOS | Acumen Pharmaceuticals, Inc. | 136.59M | 13.89% | 11,085,264 | - |
| 344 | ACTU | Actuate Therapeutics, Inc. | 133.65M | 8.29% | 87,811 | - |
| 345 | THAR | Tharimmune, Inc. | 129.66M | 10.81% | 754,448 | - |
| 346 | SGMO | Sangamo Therapeutics, Inc. | 128.17M | 0.40% | 2,160,036 | 32.88M |
| 347 | STRO | Sutro Biopharma, Inc. | 128.13M | -0.07% | 42,077 | 105.65M |
| 348 | GNLX | Genelux Corporation | 127.98M | 0.70% | 143,846 | 8.00K |
| 349 | WHWK | Whitehawk Therapeutics, Inc. | 127.25M | - | 28,208 | 14.38M |
| 350 | ACOG | Alpha Cognition Inc. | 126.76M | -2.02% | 5,401 | 7.43M |
| 351 | CGTX | Cognition Therapeutics, Inc. | 124.03M | -1.75% | 434,493 | - |
| 352 | ONCY | Oncolytics Biotech Inc. | 121.11M | -9.23% | 997,941 | - |
| 353 | KPTI | Karyopharm Therapeutics Inc. | 120.30M | -0.30% | 202,126 | 142.53M |
| 354 | ANL | Adlai Nortye Ltd. | 118.82M | 22.43% | 175,062 | -1.35M |
| 355 | VRCA | Verrica Pharmaceuticals Inc. | 118.32M | -0.27% | 16,755 | 30.83M |
| 356 | ARTV | Artiva Biotherapeutics, Inc. | 117.08M | -0.21% | 42,745 | 251.00K |
| 357 | MGNX | MacroGenics, Inc. | 116.40M | 2.22% | 670,645 | 127.63M |
| 358 | RPTX | Repare Therapeutics Inc. | 113.59M | 0.57% | 333,575 | 11.87M |
| 359 | ADAG | Adagene Inc. | 111.70M | -4.82% | 169,684 | 103.20K |
| 360 | SEER | Seer, Inc. | 108.57M | 1.05% | 71,111 | 16.38M |
| 361 | MAIA | MAIA Biotechnology, Inc. | 107.14M | 9.37% | 1,174,073 | - |
| 362 | AGEN | Agenus Inc. | 106.11M | -3.70% | 822,492 | 106.83M |
| 363 | FBIO | Fortress Biotech, Inc. | 104.91M | -0.59% | 389,123 | 62.30M |
| 364 | ANIX | Anixa Biosciences, Inc. | 102.80M | -5.52% | 188,492 | - |
| 365 | INO | Inovio Pharmaceuticals, Inc. | 102.37M | -1.32% | 841,517 | 182.34K |
| 366 | SAVA | Cassava Sciences, Inc. | 101.69M | -4.32% | 376,512 | - |
| 367 | VANI | Vivani Medical, Inc. | 101.40M | -6.08% | 687,408 | - |
| 368 | PYXS | Pyxis Oncology, Inc. | 100.87M | -0.61% | 449,721 | 2.82M |
| 369 | HYFT | MindWalk Holdings Corp. | 99.92M | -5.73% | 208,848 | 19.02M |
| 370 | KRRO | Korro Bio, Inc. | 98.88M | -2.14% | 165,365 | 7.37M |
| 371 | EXOZ | eXoZymes, Inc. | 98.45M | -1.11% | - | -700.00 |
| 372 | COYA | Coya Therapeutics, Inc. | 97.72M | -1.06% | 146,557 | 3.99M |
| 373 | CSBR | Champions Oncology, Inc. | 97.18M | 3.68% | 482 | 58.42M |
| 374 | DWTX | Dogwood Therapeutics, Inc. | 94.64M | -1.01% | 11,944 | - |
| 375 | DTIL | Precision BioSciences, Inc. | 93.64M | -7.38% | 138,466 | 698.00K |
| 376 | CBUS | Cibus, Inc. | 92.72M | 4.91% | 163,926 | 3.79M |
| 377 | MNOV | MediciNova, Inc. | 92.39M | 1.08% | 90,100 | 257.92K |
| 378 | ETHZ | ETHZilla Corporation | 92.21M | -7.44% | 413,383 | 4.11M |
| 379 | SPRB | Spruce Biosciences, Inc. | 90.98M | 4.27% | 10,065 | 697.00K |
| 380 | BMEA | Biomea Fusion, Inc. | 90.50M | -4.48% | 919,055 | - |
| 381 | ACET | Adicet Bio, Inc. | 89.04M | 4.38% | 71,801 | - |
| 382 | ATOS | Atossa Therapeutics, Inc. | 87.40M | 5.37% | 2,679,237 | - |
| 383 | KZIA | Kazia Therapeutics Limited | 85.59M | 4.59% | 209,612 | 1.20M |
| 384 | IMUX | Immunic, Inc. | 82.58M | -0.12% | 518,516 | - |
| 385 | XBIT | XBiotech Inc. | 81.71M | - | 30,069 | - |
| 386 | OKYO | OKYO Pharma Limited | 80.11M | -4.05% | 79,217 | - |
| 387 | PLRX | Pliant Therapeutics, Inc. | 79.58M | -0.38% | 348,657 | - |
| 388 | MREO | Mereo BioPharma Group plc | 79.45M | -5.27% | 6,383,825 | 500.00K |
| 389 | ALXO | ALX Oncology Holdings Inc. | 78.89M | 3.93% | 50,131 | - |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 77.42M | -2.64% | 12,394 | 501.00K |
| 391 | EQ | Equillium, Inc. | 76.73M | -0.79% | 131,964 | 4.39M |
| 392 | PYPD | PolyPid Ltd. | 76.52M | -3.77% | 76,790 | - |
| 393 | ANVS | Annovis Bio, Inc. | 76.33M | -4.32% | 323,075 | - |
| 394 | GANX | Gain Therapeutics, Inc. | 75.39M | -4.39% | 522,370 | - |
| 395 | IMA | ImageneBio, Inc. | 75.38M | -1.98% | 2,582 | 800.00K |
| 396 | CALC | CalciMedica, Inc. | 74.61M | -1.57% | 26,065 | - |
| 397 | PTHS | Pelthos Therapeutics Inc. | 73.19M | -4.20% | 59 | 7.41M |
| 398 | ENTX | Entera Bio Ltd. | 71.54M | -2.50% | 100,101 | 124.00K |
| 399 | ATYR | aTyr Pharma, Inc. | 70.03M | -1.17% | 895,662 | 190.00K |
| 400 | TVGN | Tevogen Bio Holdings Inc. | 66.95M | -5.00% | 200,610 | - |
| 401 | IFRX | InflaRx N.V. | 66.05M | -3.47% | 229,424 | 73.73K |
| 402 | ACRV | Acrivon Therapeutics, Inc. | 63.68M | -1.56% | 931,926 | - |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 63.65M | -0.92% | 251,930 | 242.00K |
| 404 | PMVP | PMV Pharmaceuticals, Inc. | 63.59M | 2.14% | 154,334 | - |
| 405 | BYSI | BeyondSpring Inc. | 63.33M | -4.94% | 8,534 | 1.88M |
| 406 | TCRX | TScan Therapeutics, Inc. | 63.27M | -2.19% | 442,328 | 8.42M |
| 407 | MGX | Metagenomi Therapeutics, Inc. | 63.04M | -0.65% | 138,637 | 30.91M |
| 408 | ATHE | Alterity Therapeutics Limited | 59.77M | 1.91% | 48,547 | 3.57M |
| 409 | LPCN | Lipocine Inc. | 59.66M | -1.51% | 28,744 | 4.32M |
| 410 | GRCE | Grace Therapeutics, Inc. | 59.27M | 0.26% | 23,877 | - |
| 411 | INKT | MiNK Therapeutics, Inc. | 58.68M | - | 4,761 | - |
| 412 | NTRB | Nutriband Inc. | 58.11M | -0.42% | 13,264 | 2.28M |
| 413 | ICCC | ImmuCell Corporation | 57.80M | 2.08% | 1,311 | 27.77M |
| 414 | RADX | Radiopharm Theranostics Limited | 56.00M | -1.22% | 9,927 | 8.20M |
| 415 | CRVO | CervoMed Inc. | 55.47M | -4.54% | 97,736 | 6.16M |
| 416 | LONA | LeonaBio, Inc. | 52.44M | -6.02% | 55,098 | - |
| 417 | OSTX | OS Therapies Incorporated | 51.80M | 0.07% | 256,431 | - |
| 418 | ALGS | Aligos Therapeutics, Inc. | 50.95M | 1.97% | 49,119 | 2.65M |
| 419 | CVM | CEL-SCI Corporation | 50.45M | 2.92% | 163,121 | - |
| 420 | NRXS | NeurAxis, Inc. | 50.39M | -2.67% | 32,239 | 3.36M |
| 421 | PDSB | PDS Biotechnology Corporation | 50.05M | -3.71% | 333,209 | - |
| 422 | QTTB | Q32 Bio Inc. | 48.97M | 1.27% | 110,226 | - |
| 423 | IBO | Impact BioMedical Inc. | 48.93M | -0.87% | 17,779 | 25.00K |
| 424 | IBIO | iBio, Inc. | 48.57M | -4.00% | 887,540 | 500.00K |
| 425 | TIL | Instil Bio, Inc. | 47.88M | -1.12% | 69,018 | - |
| 426 | ABVC | ABVC BioPharma, Inc. | 47.85M | -1.46% | 37,715 | 797.92K |
| 427 | LITS | Lite Strategy, Inc. | 47.62M | 1.97% | 179,262 | - |
| 428 | KZR | Kezar Life Sciences, Inc. | 45.48M | 0.49% | 20,866 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 45.04M | -2.24% | 50,948 | - |
| 430 | ESLA | Estrella Immunopharma, Inc. | 44.98M | 5.94% | 76,793 | - |
| 431 | INMB | INmune Bio Inc. | 44.53M | -1.47% | 150,109 | 50.00K |
| 432 | ANEB | Anebulo Pharmaceuticals, Inc. | 43.96M | - | 22,783 | - |
| 433 | PSTV | Plus Therapeutics, Inc. | 43.43M | -9.44% | 17,127,684 | 5.26M |
| 434 | VERU | Veru Inc. | 43.02M | -4.28% | 74,819 | 16.89M |
| 435 | JSPR | Jasper Therapeutics, Inc. | 42.96M | -2.23% | 150,183 | - |
| 436 | APLM | Apollomics, Inc. | 41.74M | 8.06% | 8,323 | 6.93M |
| 437 | TVRD | Tvardi Therapeutics, Inc. | 41.47M | -5.74% | 29,839 | - |
| 438 | NXTC | NextCure, Inc. | 41.47M | -0.76% | 28,259 | - |
| 439 | XLO | Xilio Therapeutics, Inc. | 41.20M | -2.99% | 70,773 | 31.80M |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 40.55M | - | 89,710 | 90.00K |
| 441 | RNTX | Rein Therapeutics Inc. | 40.05M | 11.20% | 140,335 | - |
| 442 | GLTO | Galecto, Inc. | 39.89M | -3.05% | 17,280 | - |
| 443 | HURA | TuHURA Biosciences, Inc. | 39.49M | -2.61% | 159,804 | - |
| 444 | PASG | Passage Bio, Inc. | 38.99M | -2.50% | 7,693 | - |
| 445 | GBIO | Generation Bio Co. | 38.13M | -0.62% | 55,228 | 15.27M |
| 446 | OKUR | OnKure Therapeutics, Inc. | 37.80M | -4.78% | 71,754 | - |
| 447 | ATRA | Atara Biotherapeutics, Inc. | 37.60M | -0.10% | 118,017 | 151.93M |
| 448 | LTRN | Lantern Pharma Inc. | 37.47M | -3.18% | 40,502 | - |
| 449 | CING | Cingulate Inc. | 36.64M | 4.51% | 412,384 | - |
| 450 | RNXT | RenovoRx, Inc. | 36.32M | -0.48% | 132,961 | 928.00K |
| 451 | CELU | Celularity Inc. | 36.08M | -3.02% | 5,076 | 40.58M |
| 452 | LSTA | Lisata Therapeutics, Inc. | 35.99M | -0.73% | 148,758 | 1.07M |
| 453 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 35.05M | -7.98% | 3,853,699 | - |
| 454 | KYNB | Kyntra Bio, Inc. | 34.75M | -1.72% | 13,471 | 8.30M |
| 455 | SKYE | Skye Bioscience, Inc. | 33.98M | 4.95% | 73,471 | - |
| 456 | PLUR | Pluri Inc. | 33.92M | 2.41% | 17,957 | 1.33M |
| 457 | EVAX | Evaxion A/S | 33.57M | -0.37% | 53,786 | 7.65M |
| 458 | OTLK | Outlook Therapeutics, Inc. | 33.23M | 3.04% | 1,768,567 | 1.41M |
| 459 | CUE | Cue Biopharma, Inc. | 32.90M | -5.09% | 648,531 | 7.10M |
| 460 | ANTX | AN2 Therapeutics, Inc. | 32.61M | 1.71% | 41,954 | - |
| 461 | HOWL | Werewolf Therapeutics, Inc. | 31.94M | -2.46% | 282,323 | 1.14M |
| 462 | DYAI | Dyadic International, Inc. | 31.48M | -3.33% | 10,118 | 3.34M |
| 463 | XCUR | Exicure, Inc. | 31.44M | -19.93% | 85,263 | 500.00K |
| 464 | MRKR | Marker Therapeutics, Inc. | 31.35M | -10.48% | 549,285 | 4.69M |
| 465 | GNTA | Genenta Science S.p.A. | 30.70M | -1.50% | 42,881 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 29.80M | 1.23% | 41,608 | 14.97M |
| 467 | JUNS | Jupiter Neurosciences, Inc. | 29.61M | -3.37% | 20,931 | - |
| 468 | RLYB | Rallybio Corporation | 29.32M | 3.35% | 48,283 | 674.00K |
| 469 | PTN | Palatin Technologies, Inc. | 28.43M | 0.60% | 11,108 | 8.85M |
| 470 | IGC | IGC Pharma, Inc. | 28.20M | 1.13% | 397,543 | 1.11M |
| 471 | SNTI | Senti Biosciences, Inc. | 28.00M | -1.39% | 102,723 | - |
| 472 | SER | Serina Therapeutics, Inc. | 27.85M | -9.01% | 19,900 | 116.00K |
| 473 | BOLD | Boundless Bio, Inc. | 27.76M | -1.59% | 39,503 | - |
| 474 | NRSN | NeuroSense Therapeutics Ltd. | 27.47M | -3.57% | 104,823 | - |
| 475 | LIXT | Lixte Biotechnology Holdings, Inc. | 27.44M | -5.41% | 49,429 | - |
| 476 | DARE | Daré Bioscience, Inc. | 27.29M | -2.05% | 31,432 | -57.13K |
| 477 | PLRZ | Polyrizon Ltd. | 25.38M | -0.13% | 25,776 | - |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 25.04M | -1.77% | 558,854 | 721.00K |
| 479 | HYPD | Hyperion DeFi, Inc. | 24.61M | -3.62% | 185,044 | 345.32K |
| 480 | NNVC | NanoViricides, Inc. | 24.47M | -1.34% | 225,429 | - |
| 481 | FBLG | FibroBiologics, Inc. | 24.46M | -8.08% | 525,941 | - |
| 482 | CLGN | CollPlant Biotechnologies Ltd. | 23.89M | -1.58% | 34,550 | 2.48M |
| 483 | QNTM | Quantum BioPharma Ltd. | 23.87M | -11.81% | 85,946 | - |
| 484 | KLTO | Klotho Neurosciences, Inc. | 23.13M | -3.62% | 308,250 | - |
| 485 | INTS | Intensity Therapeutics, Inc. | 23.11M | -2.90% | 1,744,711 | - |
| 486 | TRAW | Traws Pharma, Inc. | 22.61M | 16.94% | 109,296 | 2.85M |
| 487 | IOBT | IO Biotech, Inc. | 22.37M | -15.29% | 3,192,181 | - |
| 488 | NEUP | Neuphoria Therapeutics Inc. | 21.83M | -3.10% | 23,416 | 15.65M |
| 489 | INAB | IN8bio, Inc. | 21.78M | -7.08% | 60,927 | - |
| 490 | BCAB | BioAtla, Inc. | 21.74M | -3.00% | 1,548,862 | 11.00M |
| 491 | ALLR | Allarity Therapeutics, Inc. | 20.40M | -2.08% | 25,002 | - |
| 492 | CASI | CASI Pharmaceuticals, Inc. | 20.25M | 2.67% | 20,668 | 26.85M |
| 493 | PMN | ProMIS Neurosciences, Inc. | 20.15M | -0.73% | 16,781 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 19.74M | -6.68% | 38,072 | 522.00K |
| 495 | LIMN | Liminatus Pharma, Inc. | 19.73M | -5.70% | 23,103 | - |
| 496 | KTTA | Pasithea Therapeutics Corp. | 19.63M | -5.56% | 125,171 | - |
| 497 | OSRH | OSR Holdings, Inc. | 19.58M | -5.64% | 538,714 | -90.52K |
| 498 | VYNE | VYNE Therapeutics Inc. | 19.27M | -0.28% | 117,914 | 524.00K |
| 499 | LNAI | Lunai Bioworks Inc. | 19.25M | -6.41% | 541,727 | - |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 18.44M | 8.61% | 83,365 | - |
| 501 | ITRM | Iterum Therapeutics plc | 17.82M | -7.11% | 253,550 | 390.00K |
| 502 | CTXR | Citius Pharmaceuticals, Inc. | 17.07M | -3.30% | 98,664 | - |
| 503 | KALA | KALA BIO, Inc. | 16.18M | -5.34% | 552,885 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 16.13M | -1.89% | 169,700 | - |
| 505 | KAPA | Kairos Pharma, Ltd. | 15.60M | -1.69% | 76,101 | - |
| 506 | APLT | Applied Therapeutics, Inc. | 15.03M | -6.01% | 5,797,820 | 1.00M |
| 507 | CLRB | Cellectar Biosciences, Inc. | 14.97M | -6.86% | 35,332 | - |
| 508 | COCP | Cocrystal Pharma, Inc. | 14.47M | 0.96% | 33,810 | - |
| 509 | TPST | Tempest Therapeutics, Inc. | 14.44M | -1.68% | 29,241 | - |
| 510 | BCDA | BioCardia, Inc. | 13.90M | -2.24% | 37,211 | 3.00K |
| 511 | AEON | AEON Biopharma, Inc. | 13.62M | 3.61% | 78,319 | - |
| 512 | MBRX | Moleculin Biotech, Inc. | 13.52M | -6.20% | 73,162 | - |
| 513 | LGVN | Longeveron Inc. | 13.19M | 5.71% | 817,626 | 1.44M |
| 514 | NCNA | NuCana plc | 12.99M | -4.29% | 69,634 | - |
| 515 | SNGX | Soligenix, Inc. | 12.96M | -6.88% | 265,854 | 2.34K |
| 516 | BOLT | Bolt Biotherapeutics, Inc. | 12.76M | -0.45% | 5,599 | 5.20M |
| 517 | SNSE | Sensei Biotherapeutics, Inc. | 12.74M | -4.27% | 30,074 | - |
| 518 | IMNN | Imunon, Inc. | 12.68M | 2.70% | 18,062 | - |
| 519 | BLRX | BioLineRx Ltd. | 12.48M | 0.97% | 5,818 | 12.74M |
| 520 | AKTX | Akari Therapeutics, Plc | 12.24M | -2.30% | 1,044,931 | - |
| 521 | EDSA | Edesa Biotech, Inc. | 12.00M | -0.69% | 7,713 | - |
| 522 | CRIS | Curis, Inc. | 11.99M | -1.29% | 162,112 | 11.65M |
| 523 | NCEL | NewcelX Ltd. | 11.85M | -2.62% | 103,803 | - |
| 524 | PHIO | Phio Pharmaceuticals Corp. | 11.14M | -5.05% | 132,755 | - |
| 525 | GDTC | CytoMed Therapeutics Limited | 11.14M | -3.50% | 2,305 | 573.19K |
| 526 | RNAZ | TransCode Therapeutics, Inc. | 11.00M | 21.58% | 49,997 | - |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 10.73M | 3.74% | 63,651 | - |
| 528 | PMCB | PharmaCyte Biotech, Inc. | 10.06M | 5.80% | 532,129 | - |
| 529 | BRTX | BioRestorative Therapies, Inc. | 9.99M | -1.32% | 14,439 | 383.40K |
| 530 | PULM | Pulmatrix, Inc. | 9.68M | -0.31% | 932 | 3.00K |
| 531 | BIVI | BioVie Inc. | 9.31M | 1.23% | 58,361 | - |
| 532 | ERNA | Ernexa Therapeutics Inc. | 9.10M | -3.33% | 35,417 | 1,000.00 |
| 533 | ICU | SeaStar Medical Holding Corporation | 9.08M | -2.34% | 44,728 | 881.00K |
| 534 | XTLB | XTL Biopharmaceuticals Ltd. | 9.04M | -13.18% | 94,649 | 968.00K |
| 535 | EVGN | Evogene Ltd. | 9.04M | 1.03% | 13,732 | 8.02M |
| 536 | GRDX | GridAI Technologies Corp. | 9.04M | -15.81% | 76,259 | - |
| 537 | APVO | Aptevo Therapeutics Inc. | 8.92M | -0.45% | 33,128 | - |
| 538 | MTVA | MetaVia Inc. | 8.85M | -2.47% | 127,127 | - |
| 539 | IMRN | Immuron Limited | 8.50M | -0.41% | 21,591 | 4.78M |
| 540 | BCTX | BriaCell Therapeutics Corp. | 8.23M | 3.91% | 267,990 | - |
| 541 | ADXN | Addex Therapeutics Ltd | 8.19M | 4.88% | 579 | 198.82K |
| 542 | ALZN | Alzamend Neuro, Inc. | 8.15M | -2.50% | 59,196 | - |
| 543 | APM | Aptorum Group Limited | 7.90M | 0.81% | 14,392 | - |
| 544 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.89M | -2.08% | 12,643 | - |
| 545 | KPRX | Kiora Pharmaceuticals, Inc. | 7.78M | - | 11,762 | 20.00K |
| 546 | GTBP | GT Biopharma, Inc. | 7.50M | -0.98% | 456,342 | - |
| 547 | MBIO | Mustang Bio, Inc. | 7.48M | -2.38% | 35,324 | - |
| 548 | CLDI | Calidi Biotherapeutics, Inc. | 7.46M | -0.01% | 31,557 | - |
| 549 | TOVX | Theriva Biologics, Inc. | 7.26M | 3.35% | 1,721,950 | - |
| 550 | CELZ | Creative Medical Technology Holdings, Inc. | 7.20M | -1.90% | 33,672 | 6.00K |
| 551 | PCSA | Processa Pharmaceuticals, Inc. | 7.19M | -2.61% | 31,126 | - |
| 552 | PPBT | Purple Biotech Ltd | 7.15M | 0.32% | 32,935 | - |
| 553 | TCRT | Alaunos Therapeutics, Inc. | 6.67M | 2.05% | 3,034 | 6.00K |
| 554 | ACXP | Acurx Pharmaceuticals, Inc. | 6.46M | - | 11,969 | - |
| 555 | ADIL | Adial Pharmaceuticals, Inc. | 6.43M | - | 225,382 | - |
| 556 | BGMS | Bio Green Med Solution, Inc. | 6.39M | -1.14% | 13,034 | 81.00K |
| 557 | SLXN | Silexion Therapeutics Corp | 6.35M | -6.45% | 18,725 | - |
| 558 | ABP | Abpro Holdings, Inc. | 6.25M | -11.74% | 17,604 | 183.00K |
| 559 | PHGE | BiomX Inc. | 6.18M | 0.87% | 48,488 | - |
| 560 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 6.17M | 5.51% | 1,334,636 | 1.36M |
| 561 | APRE | Aprea Therapeutics, Inc. | 6.08M | 4.78% | 25,114 | 488.24K |
| 562 | XBIO | Xenetic Biosciences, Inc. | 6.00M | -1.13% | 10,635 | 2.86M |
| 563 | INDP | Indaptus Therapeutics, Inc. | 5.83M | -4.06% | 17,562 | - |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.74M | -0.67% | 32,462 | 560.00K |
| 565 | GNPX | Genprex, Inc. | 5.72M | -13.20% | 589,665 | - |
| 566 | MLEC | Moolec Science SA | 5.61M | 2.97% | 55,829 | 7.83M |
| 567 | CYCN | Cyclerion Therapeutics, Inc. | 5.60M | -4.55% | 74,531 | 2.86M |
| 568 | DCOY | Decoy Therapeutics Inc. | 5.44M | 9.21% | 637,571 | - |
| 569 | GOVX | GeoVax Labs, Inc. | 5.12M | -5.40% | 150,174 | 3.35M |
| 570 | ASBP | Aspire Biopharma Holdings, Inc. | 5.09M | 0.53% | 177,584 | 1.94K |
| 571 | SILO | Silo Pharma, Inc. | 4.81M | -2.75% | 74,853 | 72.10K |
| 572 | VIVS | VivoSim Labs, Inc. | 4.72M | -4.73% | 29,754 | 140.00K |
| 573 | MTNB | Matinas BioPharma Holdings, Inc. | 4.69M | 1.67% | 57,787 | - |
| 574 | GLMD | Galmed Pharmaceuticals Ltd. | 4.38M | -2.00% | 16,766 | - |
| 575 | PBM | Psyence Biomedical Ltd. | 4.29M | -8.43% | 152,281 | - |
| 576 | ELAB | PMGC Holdings Inc. | 4.23M | 1.71% | 82,899 | 285.95K |
| 577 | ENVB | Enveric Biosciences, Inc. | 4.23M | -2.25% | 13,309 | - |
| 578 | SPRC | SciSparc Ltd. | 4.10M | -6.69% | 718,995 | 1.31M |
| 579 | CMND | Clearmind Medicine Inc. | 3.96M | -3.65% | 19,503 | - |
| 580 | PPCB | Propanc Biopharma, Inc. | 3.95M | 5.46% | 953,331 | - |
| 581 | XRTX | XORTX Therapeutics Inc. | 3.90M | -5.25% | 20,054 | - |
| 582 | CNSP | CNS Pharmaceuticals, Inc. | 3.86M | 2.98% | 9,396 | - |
| 583 | DRMA | Dermata Therapeutics, Inc. | 3.80M | 48.85% | 24,800,435 | - |
| 584 | SCNI | Scinai Immunotherapeutics Ltd. | 3.69M | 6.55% | 196,968 | 1.15M |
| 585 | JAGX | Jaguar Health, Inc. | 3.56M | 2.44% | 735,884 | 11.79M |
| 586 | ARTL | Artelo Biosciences, Inc. | 3.47M | -0.60% | 11,673 | - |
| 587 | OGEN | Oragenics, Inc. | 3.43M | -4.07% | 144,460 | - |
| 588 | CDIO | Cardio Diagnostics Holdings, Inc. | 3.34M | -5.67% | 37,358 | 15.78K |
| 589 | LYRA | Lyra Therapeutics, Inc. | 3.31M | -8.94% | 43,723 | 600.00K |
| 590 | REVB | Revelation Biosciences, Inc. | 3.30M | -13.73% | 8,031,854 | - |
| 591 | HCWB | HCW Biologics Inc. | 3.27M | -10.37% | 102,000 | 422.03K |
| 592 | ENSC | Ensysce Biosciences, Inc. | 3.07M | -1.59% | 47,356 | 4.49M |
| 593 | BBLG | Bone Biologics Corporation | 3.03M | -2.31% | 49,678 | - |
| 594 | AZTR | Azitra, Inc. | 3.00M | -2.34% | 1,197,651 | 7.50K |
| 595 | GRI | GRI Bio, Inc. | 2.83M | - | 277,815 | - |
| 596 | ONCO | Onconetix, Inc. | 2.31M | -6.01% | 64,487 | 1.22M |
| 597 | CDT | CDT Equity Inc. | 2.10M | 0.01% | 97,567 | - |
| 598 | VRAX | Virax Biolabs Group Limited | 2.02M | 3.30% | 202,019 | 2.99K |
| 599 | ADTX | Aditxt, Inc. | 1.85M | -11.11% | 417,871 | 5.95K |
| 600 | BDRX | Biodexa Pharmaceuticals Plc | 1.83M | 1.40% | 125,118 | 104.90K |